Статті в журналах з теми "Prophylactic vaccine"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Prophylactic vaccine".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Mandic, Aljosa. "Prophylactic HPV vaccines." Archive of Oncology 17, no. 3-4 (2009): 68–71. http://dx.doi.org/10.2298/aoo0904068m.
Повний текст джерелаZhdanov, K. V., K. Kasyanenko, O. V. Mal'cev, N. I. L'vov, D. A. Lioznov, I. I. Lapikov, and K. S. Ivanov. "Evaluation of Seasonal Inactivated Influenza Vaccines Prophylactic Efficacy." Epidemiology and Vaccinal Prevention 21, no. 5 (November 19, 2022): 98–106. http://dx.doi.org/10.31631/2073-3046-2022-21-5-98-106.
Повний текст джерелаLin, YeLei. "The advancement of the HPV vaccine program: focus on adolescents." Highlights in Science, Engineering and Technology 19 (November 17, 2022): 231–35. http://dx.doi.org/10.54097/hset.v19i.2859.
Повний текст джерелаCzerwińska, Ewa, Marita Nittner-Marszalska, Janusz Zaryczański, Grzegorz Gąszczyk, Agnieszka Mastalerz-Migas, and Leszek Szenborn. "Influenza and Other Prophylactic Vaccination Coverage in Polish Adult Patients Undergoing Allergen Immunotherapy—A Survey Study among Patients and Physicians." Vaccines 10, no. 4 (April 8, 2022): 576. http://dx.doi.org/10.3390/vaccines10040576.
Повний текст джерелаToft, Lars, Martin Tolstrup, Merete Storgaard, Lars Østergaard, and Ole S. Søgaard. "Vaccination against oncogenic human papillomavirus infection in HIV-infected populations: review of current status and future perspectives." Sexual Health 11, no. 6 (2014): 511. http://dx.doi.org/10.1071/sh14015.
Повний текст джерелаKAWANA, Kei. "Human papillomavirus prophylactic vaccine." Uirusu 62, no. 1 (2012): 79–86. http://dx.doi.org/10.2222/jsv.62.79.
Повний текст джерелаLowy, Douglas R., and John T. Schiller. "Papillomaviruses: prophylactic vaccine prospects." Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1423, no. 1 (January 1999): M1—M8. http://dx.doi.org/10.1016/s0304-419x(98)00037-7.
Повний текст джерелаPaavonen, Jorma, and Matti Lehtinen. "Prophylactic Human Papillomavirus Vaccine." Women's Health 2, no. 1 (January 2006): 5–6. http://dx.doi.org/10.2217/17455057.2.1.5.
Повний текст джерелаKo, Eun-Ju, and Marjorie Robert-Guroff. "Dendritic Cells in HIV/SIV Prophylactic and Therapeutic Vaccination." Viruses 12, no. 1 (December 24, 2019): 24. http://dx.doi.org/10.3390/v12010024.
Повний текст джерелаLi, Yike, Xiaofen Huang, Zhigang Zhang, Shaowei Li, Jun Zhang, Ningshao Xia, and Qinjian Zhao. "Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation." Viruses 12, no. 1 (January 16, 2020): 109. http://dx.doi.org/10.3390/v12010109.
Повний текст джерелаKhansari, Nemat. "The Future Direction of Cancer Vaccines: An Editorial." Vaccination Research – Open Journal 6, no. 1 (December 30, 2022): e1-e2. http://dx.doi.org/10.17140/vroj-6-e007.
Повний текст джерелаBanner, David, and Alyson Ann Kelvin. "The current state of H5N1 vaccines and the use of the ferret model for influenza therapeutic and prophylactic development." Journal of Infection in Developing Countries 6, no. 06 (May 15, 2012): 465–69. http://dx.doi.org/10.3855/jidc.2666.
Повний текст джерелаKawada, Miki, Tetsuo Tsukamoto, Hiroyuki Yamamoto, Nami Iwamoto, Kyoko Kurihara, Akiko Takeda, Chikaya Moriya, Hiroaki Takeuchi, Hirofumi Akari, and Tetsuro Matano. "Gag-Specific Cytotoxic T-Lymphocyte-Based Control of Primary Simian Immunodeficiency Virus Replication in a Vaccine Trial." Journal of Virology 82, no. 20 (July 30, 2008): 10199–206. http://dx.doi.org/10.1128/jvi.01103-08.
Повний текст джерелаPaavonen, Jorma, and Matti Lehtinen. "First-Generation Vaccines against Human Papillomavirus." Women's Health 1, no. 2 (September 2005): 223–29. http://dx.doi.org/10.2217/17455057.1.2.223.
Повний текст джерелаOrme, Ian M. "Tuberculosis Vaccine Types and Timings." Clinical and Vaccine Immunology 22, no. 3 (December 24, 2014): 249–57. http://dx.doi.org/10.1128/cvi.00718-14.
Повний текст джерела&NA;. "Prophylactic paracetamol decreases vaccine immunogenicity." Reactions Weekly &NA;, no. 1275 (October 2009): 4. http://dx.doi.org/10.2165/00128415-200912750-00011.
Повний текст джерелаKim, Young Tae. "Prophylactic Vaccine for Cervical Carcinoma." Journal of the Korean Medical Association 50, no. 2 (2007): 151. http://dx.doi.org/10.5124/jkma.2007.50.2.151.
Повний текст джерелаCampo, M. Saveria, and Richard B. S. Roden. "Papillomavirus Prophylactic Vaccines: Established Successes, New Approaches." Journal of Virology 84, no. 3 (November 11, 2009): 1214–20. http://dx.doi.org/10.1128/jvi.01927-09.
Повний текст джерелаCai, Jing, Bodou Zhang, Yuqi Li, Wanfang Zhu, Toshihiro Akihisa, Wei Li, Takashi Kikuchi, Wenyuan Liu, Feng Feng, and Jie Zhang. "Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction." Vaccines 9, no. 11 (November 7, 2021): 1290. http://dx.doi.org/10.3390/vaccines9111290.
Повний текст джерелаHampson, Ian N. "Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology." Viruses 14, no. 4 (April 5, 2022): 757. http://dx.doi.org/10.3390/v14040757.
Повний текст джерелаde Oliveira, Cristina Mendes, José Humberto T. G. Fregnani, and Luisa Lina Villa. "HPV Vaccine: Updates and Highlights." Acta Cytologica 63, no. 2 (2019): 159–68. http://dx.doi.org/10.1159/000497617.
Повний текст джерелаAziz-Andersen, Kaiser Jay. "Vaccines and Therapeutics: Quality System Approach to Clinical Applications." Journal of Drug Delivery and Therapeutics 12, no. 3-S (June 15, 2022): 217–20. http://dx.doi.org/10.22270/jddt.v12i3-s.5361.
Повний текст джерелаAkhatova, Ayazhan, Azliyati Azizan, Kuralay Atageldiyeva, Aiymkul Ashimkhanova, Aizada Marat, Yerbolat Iztleuov, Assem Suleimenova, Saikal Shamkeeva, and Gulzhanat Aimagambetova. "Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State." Vaccines 10, no. 11 (November 11, 2022): 1912. http://dx.doi.org/10.3390/vaccines10111912.
Повний текст джерелаLester, S., T. Clemett, and A. Burt. "Vaccine site-associated sarcomas in cats: clinical experience and a laboratory review (1982-1993)." Journal of the American Animal Hospital Association 32, no. 2 (March 1, 1996): 91–95. http://dx.doi.org/10.5326/15473317-32-2-91.
Повний текст джерелаSchreibelt, Gerty, Daniel Benitez-Ribas, Danita Schuurhuis, Annechien J. A. Lambeck, Maaike van Hout-Kuijer, Niels Schaft, Cornelis J. A. Punt, Carl G. Figdor, Gosse J. Adema, and I. Jolanda M. de Vries. "Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells." Blood 116, no. 4 (July 29, 2010): 564–74. http://dx.doi.org/10.1182/blood-2009-11-251884.
Повний текст джерелаNOMURA, Takushi, and Tetsuro MATANOA. "Theory for prophylactic AIDS vaccine development." Uirusu 59, no. 2 (2009): 267–76. http://dx.doi.org/10.2222/jsv.59.267.
Повний текст джерелаPoole, I. Caroline Le, Hemamalini Bommiasamy, Maurizio Bocchetta, and W. Martin Kast. "Advances in prophylactic cancer vaccine research." Expert Review of Anticancer Therapy 3, no. 4 (August 2003): 537–45. http://dx.doi.org/10.1586/14737140.3.4.537.
Повний текст джерелаKhan, Taimoor, Abbas Khan, Jawad Khaliq Ansari, Muzammil Hasan Najmi, Dong-Qing Wei, Khalid Muhammad, and Yasir Waheed. "Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach." Molecules 27, no. 7 (April 6, 2022): 2375. http://dx.doi.org/10.3390/molecules27072375.
Повний текст джерелаRiolobos, Laura, Ekram Gad, Piper M. Treuting, Andrew Timms, and Mary Lenora Disis. "Development of a prophylactic vaccine for lung squamous cell carcinoma." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 169.9. http://dx.doi.org/10.4049/jimmunol.204.supp.169.9.
Повний текст джерелаSchlotthauer, Felicia, Joey McGregor, and Heidi E. Drummer. "To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity." Viruses 13, no. 5 (April 30, 2021): 805. http://dx.doi.org/10.3390/v13050805.
Повний текст джерелаBősze, Péter. "The first vaccine against cancer: the human papillomavirus vaccine." Orvosi Hetilap 154, no. 16 (April 2013): 603–18. http://dx.doi.org/10.1556/oh.2013.29593.
Повний текст джерелаSehnal, Borek, Daniel Driák, Monika Nipčová Džubáková, and Jiří Sláma. "Current data on the efficacy of prophylactic HPV vaccination in the primary prevention of cervical lesions." Česká gynekologie 87, no. 2 (April 26, 2022): 124–30. http://dx.doi.org/10.48095/cccg2022124.
Повний текст джерелаBaldwin, Susan L., Valerie A. Reese, Sasha E. Larsen, Elyse Beebe, Jeff Guderian, Mark T. Orr, Christopher B. Fox, Steven G. Reed, and Rhea N. Coler. "Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model." PLOS ONE 16, no. 3 (March 11, 2021): e0247990. http://dx.doi.org/10.1371/journal.pone.0247990.
Повний текст джерелаSchluepen, Christina, Enrico Malito, Ambra Marongiu, Markus Schirle, Elisabeth McWhinnie, Paola Lo Surdo, Marco Biancucci, et al. "Mining the bacterial unknown proteome: identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureus." Biochemical Journal 455, no. 3 (October 10, 2013): 273–84. http://dx.doi.org/10.1042/bj20130540.
Повний текст джерелаMalvolti, Stefano, Melissa Malhame, Carsten F. Mantel, Epke A. Le Rutte, and Paul M. Kaye. "Human leishmaniasis vaccines: Use cases, target population and potential global demand." PLOS Neglected Tropical Diseases 15, no. 9 (September 21, 2021): e0009742. http://dx.doi.org/10.1371/journal.pntd.0009742.
Повний текст джерелаAda, Gordon. "Desirable Immunologic Characteristics for the Development of an Ideal Vaccine." International Journal of Technology Assessment in Health Care 10, no. 1 (1994): 71–80. http://dx.doi.org/10.1017/s0266462300014008.
Повний текст джерелаDillner, Joakim, and Darron R. Brown. "Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine?" Expert Reviews in Molecular Medicine 6, no. 9 (April 19, 2004): 1–21. http://dx.doi.org/10.1017/s1462399404007653.
Повний текст джерелаLiu, Margaret A. "DNA and mRNA Vaccines for Chronic Viral Infections and Cancer: Rationale, Mechanisms, and Progress." Cancers 14, no. 23 (November 29, 2022): 5874. http://dx.doi.org/10.3390/cancers14235874.
Повний текст джерелаAguilar-Be, Ingrid, Renata da Silva Zardo, Edilma Paraguai de Souza, Gulnara Patrícia Borja-Cabrera, Miguel Rosado-Vallado, Mirza Mut-Martin, Maria del Rosario García-Miss, Clarisa Beatriz Palatnik de Sousa, and Eric Dumonteil. "Cross-Protective Efficacy of a Prophylactic Leishmania donovani DNA Vaccine against Visceral and Cutaneous Murine Leishmaniasis." Infection and Immunity 73, no. 2 (February 2005): 812–19. http://dx.doi.org/10.1128/iai.73.2.812-819.2005.
Повний текст джерелаPitisuttithum, Punnee. "HIV-1 Prophylactic Vaccine Trials in Thailand." Current HIV Research 3, no. 1 (January 1, 2005): 17–30. http://dx.doi.org/10.2174/1570162052772933.
Повний текст джерелаFlemming, Alexandra. "Steps towards a prophylactic breast cancer vaccine." Nature Reviews Drug Discovery 9, no. 8 (August 2010): 594–95. http://dx.doi.org/10.1038/nrd3233.
Повний текст джерелаZhong, Qiu, and Ronald B. Luftig. "An HIV/AIDS Prophylactic vaccine is possible." Journal of Immune Based Therapies and Vaccines 5, no. 1 (2007): 12. http://dx.doi.org/10.1186/1476-8518-5-12.
Повний текст джерелаHanke, T. "Prospect of a prophylactic vaccine for HIV." British Medical Bulletin 58, no. 1 (September 1, 2001): 205–18. http://dx.doi.org/10.1093/bmb/58.1.205.
Повний текст джерелаOkada, Masaji, Yoko Kita, Toshihiro Nakajima, Noriko Kanamaru, Satomi Hashimoto, Tetsuji Nagasawa, Yasufumi Kaneda, Shigeto Yoshida, Yasuko Nishida, and Hitoshi Nakatani. "Novel prophylactic and therapeutic vaccine against tuberculosis." Vaccine 27, no. 25-26 (May 26, 2009): 3267–70. http://dx.doi.org/10.1016/j.vaccine.2009.01.064.
Повний текст джерелаKeeling, Matt J., and Andrew Shattock. "Optimal but unequitable prophylactic distribution of vaccine." Epidemics 4, no. 2 (June 2012): 78–85. http://dx.doi.org/10.1016/j.epidem.2012.03.001.
Повний текст джерелаZhao, Bao, Xin Li, Beinan Wang, Bin Gao, and Songdong Meng. "Prophylactic cancer vaccine, from concept to reality?" Chinese Science Bulletin 59, no. 10 (February 23, 2014): 944–49. http://dx.doi.org/10.1007/s11434-014-0176-y.
Повний текст джерелаBotha, Hennie, Bruno Cooreman, Greta Dreyer, Gerhard Lindeque, Arrie Mouton, Franco Guidozzi, Tony Koller, et al. "The human papilloma virus (HPV) prophylactic vaccine." Southern African Journal of Gynaecological Oncology 1, no. 2 (January 2009): 72. http://dx.doi.org/10.1080/20742835.2009.11441143.
Повний текст джерелаSemerikov, Vladislav V., Elena S. Zubova, Vera L. Loshkareva, Lyudmila V. Sofronova, and Mariya A. Permyakova. "Bronchopulmonary Pathology Prevalence Among Premature infants and Estimation of Prophylactic Efficacy and Reactogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Premature infants with Bronchopulmonary Dysplasia." Pediatric pharmacology 16, no. 6 (February 22, 2020): 372–78. http://dx.doi.org/10.15690/pf.v16i6.2075.
Повний текст джерелаLarsen, Sasha E., Jesse H. Erasmus, Valerie A. Reese, Tiffany Pecor, Jacob Archer, Amit Kandahar, Fan-Chi Hsu, et al. "An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis." Vaccines 11, no. 1 (January 5, 2023): 130. http://dx.doi.org/10.3390/vaccines11010130.
Повний текст джерелаPitisuttithum, Punnee, and Mary Anne Marovich. "Prophylactic HIV vaccine: vaccine regimens in clinical trials and potential challenges." Expert Review of Vaccines 19, no. 2 (February 1, 2020): 133–42. http://dx.doi.org/10.1080/14760584.2020.1718497.
Повний текст джерела